Youth Substance Use Trends: Highest Rates in History

Aug.24.2022
Youth Substance Use Trends: Highest Rates in History
Marijuana and nicotine e-cigarette usage among young people hit historic highs in 2021, according to a report.

According to a report released by the National Institute on Drug Abuse in the United States, in 2021, the usage rates of cannabis and nicotine electronic cigarettes among young people reached an all-time high level.


Dr. Megan E. Patrick and her colleagues at the University of Michigan's Institute for Social Research in Ann Arbor studied drug use prevalence and trends among young people dating back to 1975 in a monitoring group study. Participants were initially sampled in 12th grade at the age of 18, and then surveyed annually until the age of 30.


Researchers have found that in 2021, the most commonly used substances among young people in the past 12 months were alcohol, marijuana, nicotine e-cigarettes, marijuana e-cigarettes, cigarettes, and other drugs (at 81.8%, 42.6%, 21.8%, 18.7%, and 18.3% respectively). The report showed a binge-drinking rate of 32.0% and a daily marijuana use rate of 10.8%. From 2020 to 2021, there was an increase in monthly marijuana e-cigarette use, a decrease in daily alcohol consumption but an increase in binge drinking, returning to the pre-pandemic levels of 2019. There was also an increase in monthly nicotine e-cigarette use, a decrease in non-medical use of narcotics other than heroin, and a decrease in non-medical use of some stimulants, including amphetamines, Adderall, cocaine, and methamphetamine.


In 2021, there was a high prevalence of cannabis, nicotine e-cigarettes, high-intensity alcohol, and hallucinogens other than LSD within a month, while smoking, excessive drinking, and the use of anesthetics other than heroin, Vicodin, and Oxycodone were at historically low levels.


Dr. Nora Volkow, Director of the National Institute on Drug Abuse, stated in a press release that "understanding how drug use affects young adults' future choices is crucial in helping the next generation avoid harm.


This article contains excerpts or reposts from third-party sources, and their copyright belongs to the original media and authors. If there is any infringement, please contact us for deletion. Any individuals or organizations who wish to repost must contact the author and refrain from reposting directly.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Special Report|From Nicotine Pouches to Jelly? A China Tobacco Patent Explores Dual-Release NRT
Special Report|From Nicotine Pouches to Jelly? A China Tobacco Patent Explores Dual-Release NRT
A patent published on February 24, 2026, by China Tobacco Hubei Industrial Co., Ltd. introduces a “nicotine jelly” product designed to combine rapid and sustained nicotine delivery. By integrating both free and microencapsulated nicotine, the product aims to address key limitations of traditional nicotine replacement therapy (NRT), while also raising new regulatory and product classification questions.
Innovation
Mar.18
NACS Urges USTR to Address Illegal E-Cigarette Exports in China Trade Engagements
NACS Urges USTR to Address Illegal E-Cigarette Exports in China Trade Engagements
NACS submitted a comment letter to USTR in a proceeding examining unfair trade practices worldwide. The letter focuses on illicit nicotine products made in China and shipped to the United States in violation of U.S. law. NACS said the U.S. electronic nicotine delivery systems market has become dominated by illicit products, mainly disposable e-cigarettes manufactured in China and sold without the marketing authorization required by the U.S. Food and Drug Administration.
Apr.16 by 2FIRSTS.ai
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
New York Nicotine Pouch Tax Moves Forward as Critics Question Public Health Impact
New York Nicotine Pouch Tax Moves Forward as Critics Question Public Health Impact
New York Governor Kathy Hochul included in her FY 2027 budget proposal a plan to impose the same 75% wholesale tax on nicotine pouches such as Zyn that applies to cigarettes. The measure is expected to raise USD 18 million in FY 2027 and USD 44 million in FY 2028 after full implementation.
Mar.30 by 2FIRSTS.ai
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA’s Center for Tobacco Products and NIH’s National Institute on Drug Abuse announced that new Wave 8 restricted-use data files from the PATH Study are now available. The files contain data collected between January 2024 and December 2024, including questionnaire data, location characteristics data, and state identifier data.
Apr.17 by 2FIRSTS.ai
Thai Vape User Numbers Rose More Than 11-Fold in Three Years, Group Says Ban Should Be Reassessed
Thai Vape User Numbers Rose More Than 11-Fold in Three Years, Group Says Ban Should Be Reassessed
A network of e-cigarette users in Thailand has urged the new government to review the country’s vape ban, saying official data show that use has risen sharply despite more than a decade of prohibition.
Mar.27 by 2FIRSTS.ai